SANDY, Utah--(BUSINESS WIRE)--OmniLytics, Inc., a biotech company focused on developing safe and natural solutions for bacterial control, today announced final EPA registration for its AgriPhage-CMM bacterial control product.
Nearly six years since OmniLytics received the first-ever US regulatory approval to use bacteriophage to control unwanted bacteria, the company has again extended its reach into the agricultural space with another crop protectant, AgriPhage-CMM. This new product targets the devastating systemic tomato disease, bacterial canker, and provides a highly effective, environmentally friendly alternative to the use of harsh chemicals. Bacterial canker is a serious tomato disease caused by Clavibacter michiganensis subsp. michiganensis (Cmm) and was first discovered in Michigan in 1909, but has grown into a global problem with outbreaks occurring annually.
Justin Reber, President & CEO of OmniLytics, stated, “OmniLytics began its journey of developing and delivering highly efficacious, 'green' products for bacterial disease control to the crop protection market nearly a decade ago and continues its development efforts to provide healthy plant protection alternatives to growers as they fight potentially devastating bacteria diseases. OmniLytics believes that reducing the levels of toxic residues on plants and food products is a vital and necessary step if we are to ultimately build a more healthy global environment and protect those along the food chain from field workers to consumers. This significant, multi-year investment underscores our ongoing commitment to service this critical market segment and to embrace our ecological obligations.”
As with its flagship AgriPhage (Xcv & Pst) products, AgriPhage-CMM can be applied directly as a foliar spray and can be used as a curative on symptomatic plants or preventively prior to visual signs of damage.
OmniLytics has additionally received final EPA registration in conjunction with its original AgriPhage products amending their application to now include organic usage on Tomato and Pepper plants as governed by the USDA National Organic Program (NOP). This extension further affirms OmniLytics' pledge to deliver safe, natural solutions to the commercial and consumer markets.
About OmniLytics, Inc.
OmniLytics is a bacteriophage company focused on developing safe, natural solutions for bacterial control. OmniLytics was the first company to work with any United States regulatory agency on a submission claiming bacteriophage as the active ingredient, and with the approval of its initial AgriPhage product in 2005, it became the first company to receive a registration from any US regulatory body. OmniLytics continues to expand its research and development of bacteriophage solutions for control of microorganisms in agricultural, food & water, industrial, pharmaceutical, and defense markets. OmniLytics’ proprietary formulas and processes optimize the use of natural bacteriophage for commercial applications. For more information about OmniLytics, visit www.omnilytics.com.